Results 1 to 10 of about 227,752 (360)

Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease [PDF]

open access: gold, 2020
Ryo Nagasawa   +8 more
openalex   +1 more source

Healthcare professionals’ perspectives on implementation of home monitoring in individuals with pulmonary fibrosis

open access: yesERJ Open Research
Introduction Home monitoring of physical parameters, symptoms and quality of life in individuals with pulmonary fibrosis (PF) could overcome gaps in clinical care by enabling early detection of disease progression, guiding patient management and ...
Delian E. Hofman   +7 more
doaj   +1 more source

Heterologous matrix metalloproteinase gene promoter activity allows In Vivo real-time imaging of Bleomycin-induced Lung fibrosis in transiently transgenized mice [PDF]

open access: yes, 2017
Idiopathic pulmonary fibrosis is a very common interstitial lung disease derived from chronic inflammatory insults, characterized by massive scar tissue deposition that causes the progressive loss of lung function and subsequent death for respiratory ...
Donofrio, Gaetano   +8 more
core   +1 more source

Semantic Segmentation of Pathological Lung Tissue with Dilated Fully Convolutional Networks

open access: yes, 2018
Early and accurate diagnosis of interstitial lung diseases (ILDs) is crucial for making treatment decisions, but can be challenging even for experienced radiologists. The diagnostic procedure is based on the detection and recognition of the different ILD
Anthimopoulos, Marios   +5 more
core   +1 more source

Understanding emotional and practical challenges of initiating oxygen therapy in pulmonary fibrosis: insights from a patient-centered survey

open access: yesBMC Pulmonary Medicine
Background Pulmonary fibrosis (PF) causes respiratory insufficiency due to progressive lung scarring and impaired gas exchange. Although no curative treatment exists, pharmacological therapies may slow progression, while oxygen therapy alleviates ...
Marjolein Drent   +4 more
doaj   +1 more source

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

open access: yesBMC Pulmonary Medicine, 2019
Background Fibrosing, non-idiopathic pulmonary fibrosis (non-IPF) interstitial lung diseases (fILDs) are a heterogeneous group of diseases characterized by a different amount of inflammation and fibrosis. Therapy is currently based on corticosteroids and/
Sebastiano Emanuele Torrisi   +13 more
doaj   +1 more source

Idiopathic pulmonary fibrosis: evaluation of progression and prognosis after the ATS/ERS/JRS/ALAT statement 2011 [PDF]

open access: yes, 2012
Objectives The prediction of usual interstitial pneumonia (UIP) progression and prognosis by the a application of HRCT criteria pattern recommended by ATS/ERS/JALAT guidelines 2011 Materials and methods Two radiologists after assessing the baseline HRCT ...
ROMEI, CHIARA
core  

Diagnostic test interpretation and referral delay in patients with interstitial lung disease. [PDF]

open access: yes, 2019
BACKGROUND:Diagnostic delays are common in patients with interstitial lung disease (ILD). A substantial percentage of patients experience a diagnostic delay in the primary care setting, but the factors underpinning this observation remain unclear.
Adegunsoye, Ayodeji   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy